GENE ONLINE|News &
Opinion
Blog

China
Junshi’s PD-1 Antibody Meets Endpoint In Phase 3 Lung Cancer Trial
2023-01-19
CARsgen Taps Huadong to Commercialize Multiple Myeloma CAR-T in China
2023-01-17
Antengene To Pair CD73 Inhibitor With Merck’s Keytruda In Clinical Collaboration
2022-12-27
LG Chem Lands Innovent As China Partner For Gout Candidate
2022-12-15
China’s Tenacia Books Marinus For $266 Million To Market Seizure Med
2022-11-20
Moderna To Collaborate With Harbour BioMed On Nucleic Acid-Based Cancer Therapies
2022-11-14
Zenas Picks Up $118 Million To Advance Phase 3 For Autoimmune Candidate
2022-11-10
Cyagen, Neurophth Ink $140 Million Deal For AI-Designed AAV Capsids
2022-11-08
Eucure Biopharma, Syncromune To Develop Intratumoral Immunotherapy
2022-10-20
WuXi Biologics, Toregem BioPharma To Develop Tooth-Regenerating Antibody
2022-10-14
Sanofi Invests in Innovent to Gain Stronger Foothold in China
2022-08-05
Everest, Calliditas Win First Approval for Rare Kidney Disease Drug in Europe
2022-07-18
Zhiyi Biotech Finishes Series B Funding With $45 Million For Live Biotherapeutics
2022-07-11
Brii Biosciences Begins Marketing COVID-19 Antibody Cocktail Therapy in China
2022-07-07
WuXi Biologics Adds Microbial Fermentation to CDMO Offering in Hangzhou
2022-07-05
1 2 3 7
LATEST
NDA for Biogen-Sage’s Zuranolone Accepted by FDA, Marking Another Step Forward in Depression Drug Development
2023-02-07
BMS Returns $475 Million Cancer Asset To Dragonfly Therapeutics
2023-02-07
FDA Expands Approval For Takeda’s Takhzyro To Prevent Hereditary Angioedema Attacks
2023-02-06
Abbott’s New Technologies for Arrhythmia Treatment Secure FDA and European Approval
2023-02-04
First Human Trial for Marburg Virus Vaccine Reports Success
2023-02-03
Karuna Licenses Goldfinch’s Mood Disorder Candidates For Potential $535 Million
2023-02-03
Novel Bioengineered Wearable Edgeless Skin Brings Hope to Revolutionize Plastic and Reconstructive Surgery
2023-02-03
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!